期刊
BIOLOGICAL CHEMISTRY
卷 396, 期 11, 页码 1223-1231出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/hsz-2015-0106
关键词
ChIP-Seq; glucocorticoid receptor; inflammation; transactivation; transgenic mice; transrepression
资金
- Deutsche Forschungsgemeinschaft 'Immunobone', Collaborative Research Centre 1149 from KaroBioScience Foundation [SPP 1468 Tu220/6-2]
- EU FP7 Programme BRAINAGE
Glucocorticoids (GCs) are the most commonly used anti-inflammatory agents to treat inflammatory and immune diseases. However, steroid therapies are accompanied by severe side-effects during long-term treatment. The dogma that transrepression of genes, by tethering of the glucocorticoid receptor (GR) to DNA-bound pro-inflammatory transcription factors, is the main anti-inflammatory mechanism, is now challenged. Recent discoveries using conditional GR mutant mice and genomic approaches reveal that transactivation of anti-inflammatory acting genes is essential to suppress many inflammatory disease models. This novel view radically changes the concept to design selective acting GR ligands with a reduced side-effect profile.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据